Elsevier Announces the Launch of Open Access Journal: Pathogenesis
OXFORD, England, January 29, 2014 /PRNewswire/ –
OA journal Pathogenesis published on behalf of The Royal College of
Elsevier [http://www.elsevier.com ], world-leading provider of scientific, technical
and medical information products and services, announces the launch of open access
journal, Pathogenesis [http://www.journals.elsevier.com/pathogenesis ].
Pathogenesis [http://www.journals.elsevier.com/pathogenesis ] will be published on
behalf of The Royal College of Pathologists [http://www.rcpath.org ], a professional
membership organization committed to setting and maintaining professional standards and
promoting excellence in the practice of Pathology. The College represents 19 pathology
specialties and has over 10,000 members working in hospital laboratories, universities and
Pathogenesis will provide a home for research covering all areas of illness and normal
cellular and molecular development in human and veterinary disease. The journal
Pathogenesis will publish peer reviewed original scientific research articles and high
quality reviews, editorials and letters to the editor which report on multidisciplinary
areas of Molecular and Diagnostic Pathology, Cellular Mechanisms as well as aspects of
Haematology, Proteomics, Virology, Microbiology and Chemical Pathology.
The Editor-in-Chief of the journal, Professor Finbarr Cotter, Barts Cancer Institute,
Queen Mary University of London, UK said of the launch, “This is a tremendous cooperation
between The Royal College of Pathologists and Elsevier, one which confirms the major
commitment by the College towards the modernization of the field of pathology with both
academic and molecular pathology leading the way.”
Professor Cotter will work closely with Section Editors: Professor Ian Cree,
University Hospital Coventry and Warwickshire, UK and Dr George Vassilou, Wellcome Trust
Sanger Institute, Cambridge, UK.
“We are delighted to announce the launch of this new open access journal. We look
forward to working together with the journal editors and The Royal College of Pathologists
offering their members, researchers and clinicians a platform through which they can
publish their research quickly and make it widely available,” said Rachel Garland,
Publisher at Elsevier.
For more information or to submit an article, go to:
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today,
researchers can choose to publish open access in over 1,600 established peer-reviewed
journals as well as 82 full open access journals and these numbers will continue to grow
rapidly. All of Elsevier’s open access publications have been peer reviewed, ensuring that
the broader community not only reads the latest research but that it is factual, original
and of the highest quality and ethical standards. For more information about Elsevier’s
open access program, visit http://www.elsevier.com/openaccess.
Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and 25,000 book titles,
including major reference works from Mosby and Saunders. Elsevier’s online solutions
include ScienceDirect [http://www.sciencedirect.com ], Scopus [http://www.scopus.com ],
SciVal [http://info.scival.com ], Reaxys [http://www.elsevier.com/reaxys ], ClinicalKey
[https://www.clinicalkey.com ] and Mosby’s Suite [http://www.confidenceconnected.com ],
which enhance the productivity of science and health professionals, helping research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world leading provider of professional information
solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media contact Mareille Prevo Elsevier +31-204853783 email@example.com